Showing results (61-70 of 133) with videos related to
Sort By:
Pageof 14
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 17, 2008
Combined assessment of metabolic and volumetric changes for assessment of tumor response in patients with soft-tissue sarcomasMatthias R Benz, Martin S Allen-Auerbach, Fritz C Eilber, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 16, 2014
Impact of 68Ga-DOTATATE PET/CT on the management of neuroendocrine tumors: the referring physician's perspectiveKen Herrmann, Johannes Czernin, Edward M Wolin, et al.Journal of Neurotrauma|March 6, 2004
Selective metabolic reduction in gray matter acutely following human traumatic brain injuryHsiao-Ming Wu, Sung-Cheng Huang, Naoya Hattori, et al.Molecular Imaging and Biology|October 13, 2005
Performance of 2-deoxy-2-[F-18]fluoro-D-glucose positron emission tomography and integrated PET/CT in restaged breast cancer patientsBarbara J Fueger, Wolfgang A Weber, Andrew Quon, et al.Molecular Imaging and Biology|December 20, 2005
Usefulness of 3'-[F-18]fluoro-3'-deoxythymidine with positron emission tomography in predicting breast cancer response to therapyBetty S Pio, Cecilia K Park, Richard Pietras, et al.Proceedings of the National Academy of Sciences of the United States of America|February 7, 2009
Noninvasive prediction of tumor responses to gemcitabine using positron emission tomographyRachel E Laing, Martin A Walter, Dean O Campbell, et al.Neurobiology of Aging|December 8, 2004
Estrogen use and brain metabolic change in postmenopausal womenNatalie L Rasgon, Daniel Silverman, Prabha Siddarth, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 4, 2007
In vivo quantitation of glucose metabolism in mice using small-animal PET and a microfluidic deviceHsiao-Ming Wu, Guodong Sui, Cheng-Chung Lee, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2007
Predicting treatment response of malignant gliomas to bevacizumab and irinotecan by imaging proliferation with [18F] fluorothymidine positron emission tomography: a pilot studyWei Chen, Sibylle Delaloye, Daniel H S Silverman, et al.Bioorganic & Medicinal Chemistry Letters|September 13, 2005
Synthesis of 4-(5-[18F]fluoromethyl-3-phenylisoxazol-4-yl)benzenesulfonamide, a new [18F]fluorinated analogue of valdecoxib, as a potential radiotracer for imaging cyclooxygenase-2 with positron emission tomographyTatsushi Toyokuni, J S Dileep Kumar, Joseph C Walsh, et al.Pageof 14